Activated AMPK improves metabolic status by regulating signaling pathways and metabolic pathways associated with insulin resistance to enhance insulin sensitivity to treat MAFLD (Fouqueray et al., 2021). The gene discussed is PRKAA1; the disease is Insulin resistance.